The document discusses recent updates in dissolution techniques. It begins with an introduction to dissolution testing and its importance. It then discusses several advancements in dissolution apparatus designs that improve hydrodynamics and allow for faster, more accurate testing of different dosage forms like floating tablets and aerosols. Detection method updates using fiber optics, potentiometric sensors, and FTIR spectroscopy are also covered. The document concludes that dissolution testing continues growing in importance to regulatory agencies and presents challenges to develop new methods to evaluate emerging drug delivery systems.
Introduction to Dissolution equipment's, Calibration of dissolution apparatus, Dissolution procedure development and validation, Dissolution method development for generic drug products.
Presentation about dissolution apparatus testing machine for tablet and new version which is manufactured by lab 8 "Industrial Pharmacy Course" faculty of pharmacy october 6 university.
we added new modification which is already applied and others not applied due to high cost but suggested.
and all modifications are approved from industrial pharmacy department O6U.
Introduction to Dissolution equipment's, Calibration of dissolution apparatus, Dissolution procedure development and validation, Dissolution method development for generic drug products.
Presentation about dissolution apparatus testing machine for tablet and new version which is manufactured by lab 8 "Industrial Pharmacy Course" faculty of pharmacy october 6 university.
we added new modification which is already applied and others not applied due to high cost but suggested.
and all modifications are approved from industrial pharmacy department O6U.
The dissolution test is an important means of assuring the continuing performance of non-solution orally administered drug products. The development of a dissolution test procedure is briefly discussed in USP general information chapter In Vitro and In Vivo Evaluation of Dosage Forms 1088, whereas general information chapter Validation of Compendial Procedures 1225 gives limited validation information for dissolution testing. Neither of these two chapters provides a level of detail and focus sufficient for dissolution testing. In 2001, a Stimuli article provided an initial rationale and discussion of content for a new general information chapter. The new chapter, The Dissolution Procedure: Development and Validation 1092, was intended to supplement the information in 1088 and 1225 and provided step-by-step detail for development and validation as well as offering information on new technology and equipment. In 2006, the chapter became official with the Second Supplement to USP 29–NF 24 (2–4).
The General Chapters—Dosage Forms Expert Committee 2010–2015 placed the review and possible revision of The Dissolution Procedure: Development and Validation 1092 on its work plan for the 2010–2015 revision cycle (2011) .
Drug Regulations has prepared this presentation based on the proposed chapter.
Analytical method validation, ICH Q2 guidelineAbhishek Soni
Analytical Method Validation, ICH Q2 Guideline.
General principles related to the analytical method validation.
Validation of analytical method as per International Council for Harmonisation(ICH) guidelines and the United States Pharmacopeia(USP).
Glossary.
Useful in understanding the terms :
Specificity
Linearity
Range
Accuracy
Precision
Detection limit
Quantitation limit
Robustness
Ruggedness
System suitability testing
Basic Approach to Dissolution Method Development – Challenges and Regulatory ...Dr. Harshal Pawar
This presentation explains the theoretical as well as practical aspects of dissolution. It provides a systematic and scientific path for development of dissolution method for a new pharmaceutical product.
Methods of Solubility Enhancement bt Mr.Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Biopharmaceutics & Pharmacokinetics
M.Pharmacy Sem 1
Savitribai Phule Pune University
Introduction :-
Solubility :-
“Solubility is the property of a solid, liquid, or gaseous chemical substance called solute to dissolve in a solid, liquid, or gaseous solvent to form a homogeneous solution of the solute in the solvent.”
Solubalization :-
“ A Preparation of thermodynamically stable isotropic solution of a substance normally insoluble or slightly soluble in a given solvent by introduction of an additional component
Importance of Solubility :-
Therapeutic efeectivness of a drug depends upon the bioavailability & ultimately upon the solubility of drug molecules
Solubility is one of the important parameter to achieve desired concentration of a drug in systemic circulation for pharmacological ressponse to be shown.
Currently only 8% of new drugs have both high solubility & Permeability.
Nearly 40% of the new chemical entities currently being discovered are poorely water soluble
Methods :-
Spray freezing into liquid (SFL)
Ultra-Rapid Freezing
Kneading Technique
Co-precipitation
Solubalizing Agents
The dissolution test is an important means of assuring the continuing performance of non-solution orally administered drug products. The development of a dissolution test procedure is briefly discussed in USP general information chapter In Vitro and In Vivo Evaluation of Dosage Forms 1088, whereas general information chapter Validation of Compendial Procedures 1225 gives limited validation information for dissolution testing. Neither of these two chapters provides a level of detail and focus sufficient for dissolution testing. In 2001, a Stimuli article provided an initial rationale and discussion of content for a new general information chapter. The new chapter, The Dissolution Procedure: Development and Validation 1092, was intended to supplement the information in 1088 and 1225 and provided step-by-step detail for development and validation as well as offering information on new technology and equipment. In 2006, the chapter became official with the Second Supplement to USP 29–NF 24 (2–4).
The General Chapters—Dosage Forms Expert Committee 2010–2015 placed the review and possible revision of The Dissolution Procedure: Development and Validation 1092 on its work plan for the 2010–2015 revision cycle (2011) .
Drug Regulations has prepared this presentation based on the proposed chapter.
Analytical method validation, ICH Q2 guidelineAbhishek Soni
Analytical Method Validation, ICH Q2 Guideline.
General principles related to the analytical method validation.
Validation of analytical method as per International Council for Harmonisation(ICH) guidelines and the United States Pharmacopeia(USP).
Glossary.
Useful in understanding the terms :
Specificity
Linearity
Range
Accuracy
Precision
Detection limit
Quantitation limit
Robustness
Ruggedness
System suitability testing
Basic Approach to Dissolution Method Development – Challenges and Regulatory ...Dr. Harshal Pawar
This presentation explains the theoretical as well as practical aspects of dissolution. It provides a systematic and scientific path for development of dissolution method for a new pharmaceutical product.
Methods of Solubility Enhancement bt Mr.Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Biopharmaceutics & Pharmacokinetics
M.Pharmacy Sem 1
Savitribai Phule Pune University
Introduction :-
Solubility :-
“Solubility is the property of a solid, liquid, or gaseous chemical substance called solute to dissolve in a solid, liquid, or gaseous solvent to form a homogeneous solution of the solute in the solvent.”
Solubalization :-
“ A Preparation of thermodynamically stable isotropic solution of a substance normally insoluble or slightly soluble in a given solvent by introduction of an additional component
Importance of Solubility :-
Therapeutic efeectivness of a drug depends upon the bioavailability & ultimately upon the solubility of drug molecules
Solubility is one of the important parameter to achieve desired concentration of a drug in systemic circulation for pharmacological ressponse to be shown.
Currently only 8% of new drugs have both high solubility & Permeability.
Nearly 40% of the new chemical entities currently being discovered are poorely water soluble
Methods :-
Spray freezing into liquid (SFL)
Ultra-Rapid Freezing
Kneading Technique
Co-precipitation
Solubalizing Agents
ABSTRACT The purpose of this study was to prepare and evaluate immediate release itraconazole pellets and comprehensive studies of the same. The itraconazole pellets is prepared using fluid bed processer with different concentration of HPMC (Hydroxy Propyl Methyl Cellulose). The physicochemical compatibility of the drug and the excipient studied by differential scanning calorimetry. The prepared pellets were physically evaluated with size, shape, bulk density, tapped density, compressibility index, hausners ratio, angle of repose, sieve analysis, surface roughness, density, moisture content, assay and drug release etc. The in vitro drug release profile from pellets shows that all the formulation release more than 75% drug within 90min. Optimized formulations were found to have HPMC concentration 2-5% of total weight of pellets to maximize high-quality surface, desired release, and size distribution within the range. These results indicate that pellets containing 10 % HPMC of total weight of pellets give better quality of itraconazole pellets for immediate release. Key Words: Itraconazole, Hydroxyl propyl methyl cellulose and Immediate release.
ABSTRACT
Overactive bladder (OAB) is a prevalent condition which has an adverse effect on quality of life. The presence
of urgency incontinence confers significant morbidity above and beyond that of OAB sufferers who are
continent. The primary treatment for OAB and urgency incontinence is a combination of behavioral measures
and antimuscarinic drug therapy. The ideal antimuscarinic agent should effectively relieve the symptoms of
OAB, with the minimum of side effects; it should be available as a once-daily sustained release formulation
and in dosage strength that allows easy dose titration for the majority of sufferers. Solifenacin succinate was
launched in 2005 and has been shown in both short and long term clinical trials to fulfill these requirements.
Solifenacin is a competitive M3 receptor antagonist with a long half-life (45-68 hours). It is available in two
dosage strengths namely a 5 or 10 mg once-daily tablet. The efficacy and tolerability of solifenacin for the
treatment of all symptoms of OAB has been evaluated in a number of large, placebo controlled, randomized
trials. Long-term safety, efficacy, tolerability and persistence with treatment have been established in an open
label 40 week continuation study.
KEYWORDS
Solifenacin, Urinary incontinence, Overactive bladder and Wet granulation method.
Solubility enhancement technique of BCS Class II drug by Solvent EvaporatiomKaustav Dey
I am very happy to share with you my B.Pharm Final semester Presentation. The topic of the presentation was “SOLUBILITY ENHANCEMENT TECHNIQUE OF BCS CLASS II DRUG BY SOLVENT EVAPORATION TECHNIQUE – FORMULATION & EVALUATION" which i have done under the esteemed guidance of Dr. Goutam Kumar Jena. It was a great experience to deliver this topic infront of the expert jury. I would also like thank all my teammates especially Agniv Masanta for his efforts. I hope everyone of you will like presentation and the research and efforts behind it.Thank you for giving your precious time. #research #science #thankyou #experience #share
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
3. [3][3]
Amount of drug substance that goes into solution per unit time under
standardized conditions of liquid/solid interface, temperature and solvent
composition
Dissolution is a prerequisite for the drug absorption
Absorption of a drug is possible only when it is present in solution form,
wherein the molecules are independent and assume molecular dispersion
Correlate in vitro with in vivo drug release characteristics
Costa P et al., Eur J Pharm Sci.2001;13(2):123-33.
6. [6]
Pharma industries trying to test more samples in fraction of time
Faster the test faster the product deliver to market
Requirements of increase quantity while increasing quality
Labour intensive process, require many steps, analyst to analyst
variability
Ensure consistency, quality, ease of use and increased productivity
http://www.americanlaboratory.com/913-technical articles
8. [8]
Coning effect will lead to wrong interpretation of the results
Laminar flow does not mimic the
turbulence flow in the gastrointestinal tract
Improved hydrodynamics, improved product characterization and prevents
accumulation of disintegrating material
[8] Qureshi SA, Dissolut Technol. 2004;11:13-21.
Crescent shaped spindle
9. [9]
During sample withdrawing fluid dynamics of media get disturbed
Low sampling rate, difficult to study fast releasing dosage forms
Hollow shaft sampling method
Withdraw the samples without disturbing the flow dynamics of media
Sampling rate upto 20 seconds per sample is possible
[9] Pillay V et al., J Contr Rel.1998;55(1):45-55.
10. [10]
For low dose drugs classical method of dissolution testing is not well suited
[10]
Analytical method is not sensitive enough to detect the low concentration of
the drug in the formulation
Small-volume dissolution apparatus
Apply gentle agitation important for immediate release tablets
Low material consumption
Results obtained are comparable to official apparatus
Scheubel E et al., Pharmaceutics.2010;2(4):351-63.
11. [11]
Floating tablets
• Volume of dissolution medium (900 mL) is very high as compared to
stomach content
• Adherence of dosage form on the shaft,
• Problems during sample collection
• Test does not mimic acid release from stomach lining and gastric
emptying through pylorus opening
Modified Rossett-Rice test
[11] Gohel MC et al., Dissolut Technol.2004;11:23-25.
12. [12]
Aerosol
• Have to dissolve in different environment
• No in vitro test system to study aerosols
[12]
Davies and Feddah apparatus
Advantages are flexibility to control pH, flow rate, viscosity and all
the particles experience same intensity of solvent flow
Updates in dosage form
Dissolution cell
Davies NM et al., Int J Pharm. 2003;255(1):175-87.
13. [13]
Controlled release parenterals
• Number of controlled release parenterals marketed products are
increasing
• There is constant need of dissolution testing apparatus
[13]
Non-compendial methods
Sample and separate method Dialysis method
Barzilay R et al., J Pharm Pharmacol.1968;20(1):232-38.
14. [14]
Sublingual tablets
• Sublingual tablets have to dissolve in different physiological
conditions as compared to gastric conditions
• Current apparatus and methods not simulate these conditions
[14]
One unit apparatus
Sreebny LM et al., Gerodontology.1986;5(2):75-99.
1. 1. Funnel 2. Clamp 3. Filter 4. Glass base
2. 5. Stopper 6. Collection tube 7. Buchner flask
X mL dissolution
medium Tablet for
testing
Tablet
residue
Vaccum
pump off
Vaccum
pump off
Vaccum
pump on
To HPLC
analysis
15. [15]
Medicated chewing gum
• Continuous mastication is required for release of drug from medicated
chewing gum making dissolution testing different
[15]
Single module apparatus
Azarmi S et al., Int J Pharm.2007;328(1):12-21.
16. [16]
Poorly soluble drugs
• Conventional apparatus fail to correlate pH changes with dissolution
profile, not simulate the release of acid from gastric lining
[16]
Multi compartment dissolution apparatus
Rohrs BR, Dissolut Technol.2001;8(3):6-12.
1. 1. Gastric reservoir
2. 2. Intestinal reservoir
3. A. Gastric compartment
4. B. Intestinal compartment
5. C. Sample collector
6. D. Filter
D
17. [17]
Updates in detection methods
[17]
Manual sampling is slow process
Accuracy is low
Multiple fibre optic system
Advantages
Testing procedure is simplified
More economical
Accuracy increased
Disadvantages
Not used in turbid media
The tablet matrix debris builds up on the
probe mirrors
Bynum K et al., Dissolut Technol.1999;6(4):11-19
pION rainbow fibre
optic
18. [18]
Dissolution testing using potentiometric sensors
Advantages
Insensitive towards undissolved
particles and air bubbles
Response time of the sensors is fast
Used in turbid and complex media
Used for measuring nanosuspensions
Disadvantages
Each API requires
preconditioning of electrode
Electrode disturbs flow
dynamics of media
Bohets H et al., Anal Chim Acta.2007;581(1):181-91.
• Correlates potential change with
concentration, consists of reference
and standard electrode
19. [19]
Dissolution studies with FTIR spectroscopic imaging
• This technique provides images of a dosage form during there
dissolution
Effect of different factors on drug release can be explored
Mechanism of drug release can be studied
Vanderweerd J et al., J Cont Rel.2004;98(2):295-05.
20. [20]
Conclusion and future perspective
Dissolution testing is growing continuously as a critical technology to
pharmaceutical analysis
Worldwide regulatory agencies are relying on the dissolution test
more and more for relevance to in vivo performance
Many scientist, organizations, manufacturers are actively developing
new and more sophisticated apparatus
Gray V et al., Pharm Forum.1997;23:83-97.
As new chemical entities and new drug delivery systems are
developed, there are challenge to develop new methods for in vitro
drug release determination